%0 Journal Article
%T Minimally important differences and risk levels for the Composite Asthma Severity Index
%A Agustin Calatroni
%A Andrew H. Liu
%A Christine A. Sorkness
%A Edward M. Zoratti
%A Gurjit K. Khurana Hershey
%A Jeremy J. Wildfire
%A Joseph B. West
%A Melanie Makhija
%A Meyer Kattan
%A Peter J. Gergen
%A Rebecca Gruchalla
%A Rebecca Z. Krouse
%A Robert A. Wood
%A Stephen J. Teach
%J Journal of Allergy and Clinical Immunology
%D 2017
%R 10.1016/j.jaci.2016.08.041
%X The Composite Asthma Severity Index (CASI) is a comprehensive severity scale combining
multiple facets of asthma severity: impairment, risk, and treatment.1 The CASI score,
which was developed as a research tool for intervention studies, ranges from 0 to
20 points, with higher scores indicating higher levels of severity, and includes 5
domains: day symptoms and albuterol use, night symptoms and albuterol use, controller
treatment, lung function measures, and exacerbations. This report expands on the introduction
of the CASI score in Wildfire et£¿al1 by determining risk levels, the minimally important
difference (MID), and the suggested effect size for the score.
%U https://www.jacionline.org/article/S0091-6749(16)31125-3/abstract